SHARON TETLOW

CIK 1328565 · Acting CFO & Treasurer · last filed 2025-06-25

"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.

Loading insider history…
Disclosed Exposure

$65.1K

Companies

4

Total Filings

16

Lifetime Open-Market Net

$0

Holdings By Company

Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
Symbol Role Shares Price Disclosed Exposure Lifetime OM Net Filings Latest Filed
GPCR Director $42.93 $0 2 2025-06-25
DICE Therapeutics, Inc. (DICE) Delisted Director 0 $47.55 $0 $0 3 2023-08-09
CBIO Director 3,635 $17.92 $65.1K $0 5 2021-07-02
CELL GENESYS INC (CEGE) Delisted SVP & CFO 0 $0 5 2009-10-15

Recent Filings · Page 2 of 2

16 filings
Form 4 transactions across all companies, newest first.
Filed Symbol Action Net Shares Net $ Link
2014-07-15 Buy (P) +3,000 $17.5K
2009-10-15 CELL GENESYS INC (CEGE) Delisted Disp (D) −18,449 $0 EDGAR
2008-08-01 CELL GENESYS INC (CEGE) Delisted Tax (F) −9,051 -$28.1K EDGAR
2008-02-08 CELL GENESYS INC (CEGE) Delisted Grant (A) $0 EDGAR
2007-08-01 CELL GENESYS INC (CEGE) Delisted Grant (A) +25,000 $0 EDGAR
2007-02-09 CELL GENESYS INC (CEGE) Delisted Grant (A) $0 EDGAR
Showing 1116 of 16
Page 2 of 2
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.